MCRB
Price:
$0.877
Market Cap:
$149.74M
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the treatment of clostridium difficile infection (CDI). It is also developing SER-155, a cultivated bacteria microbiome drug, which is Phase Ib clinical trial to reduce incidences of gastrointestinal infections, bloodstream infections, and graft versus host diseases in immunocompromised patients receiving allogeneic hematopoietic stem cell transplantation...[Read more]
Industry
Biotechnology
IPO Date
2015-06-26
Stock Exchange
NASDAQ
Ticker
MCRB
According to Seres Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Seres Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), MCRB's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Seres Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Seres Therapeutics, Inc. (MCRB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Seres Therapeutics, Inc.’s Dividend Yield is less than Syros Pharmaceuticals, Inc. (0%), less than Iovance Biotherapeutics, Inc. (0%), less than Veracyte, Inc. (0%), less than NanoString Technologies, Inc. (0%), less than Fate Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $6.73M | |
0% | $2.78B | |
0% | $3.32B | |
0% | $5.07M | |
0% | $305.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seres Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Seres Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Seres Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Seres Therapeutics, Inc. (MCRB)?
What is the highest Dividend Yield for Seres Therapeutics, Inc. (MCRB)?
What is the 3-year average Dividend Yield for Seres Therapeutics, Inc. (MCRB)?
What is the 5-year average Dividend Yield for Seres Therapeutics, Inc. (MCRB)?
How does the current Dividend Yield for Seres Therapeutics, Inc. (MCRB) compare to its historical average?